Objectives The digitalisation of sexual and reproductive health (SRH) services offers valuable opportunities to deliver contraceptive pills and chlamydia treatment by post. We aimed to examine the acceptability of remote prescribing and ‘medication-by-post’ in SRH. Study design An online survey assessing attitudes towards remote management was distributed in three UK SRH clinics and via an integrated sexually transmitted infection (STI) postal self-sampling service. Logistic regressions were performed to identify potential correlates. Results There were 1281 participants (74% female and 49% <25 years old). Some 8% of participants reported having received medication via post and 83% were willing to receive chlamydia treatment and contraceptive pills by post. Lower acceptability was observed among participants who were: >45 years old (OR 0.43 (95% CI 0.23–0.81)), screened for STIs less than once annually (OR 0.63 (0.42–0.93)), concerned about confidentiality (OR 0.21 (0.90–0.50)), concerned about absence during delivery (OR 0.09 (0.02–0.32)) or unwilling to provide blood pressure readings (OR 0.22 (0.04–0.97)). Higher acceptability was observed among participants who reported: previously receiving medication by post (OR 4.63 (1.44–14.8)), preference for home delivery over clinic collection (OR 24.1 (11.1–51.9)), preference for home STI testing (OR 10.3 (6.16–17.4)), ability to communicate with health advisors (OR 4.01 (1.03–15.6)) and willingness to: register their real name (OR 3.09 (1.43–10.6)), complete online health questionnaires (OR 3.09 (1.43–10.6)) and use generic contraceptive pills (OR 2.88 (1.21–6.83)). Conclusions Postal treatment and entering information online to allow remote prescribing were acceptable methods for SRH services and should be considered alongside medication collection in pharmacies. These methods could be particularly useful for patients facing barriers in accessing SRH. The cost-effectiveness and implementation of these novel methods of service delivery should be further investigated. Data are available upon reasonable request. No additional data.

中文翻译：

---

避孕药远程处方和邮寄服务以及简单沙眼衣原体治疗的可接受性

目标 性与生殖健康 (SRH) 服务的数字化为邮寄避孕药和衣原体治疗提供了宝贵的机会。我们旨在检查远程处方和“邮寄用药”在 SRH 中的可接受性。研究设计 一项评估远程管理态度的在线调查分布在英国的三个 SRH 诊所，并通过综合性传播感染 (STI) 邮政自我采样服务进行。进行逻辑回归以确定潜在的相关性。结果 共有 1281 名参与者（74% 女性和 49% <25 岁）。大约 8% 的参与者报告通过邮寄方式接受药物治疗，83% 的人愿意通过邮寄方式接受衣原体治疗和避孕药。在以下参与者中观察到较低的可接受性：> 45 岁（OR 0. 43 (95% CI 0.23–0.81))，每年筛查 STI 不到一次 (OR 0.63 (0.42–0.93))，担心保密性 (OR 0.21 (0.90–0.50))，担心分娩期间缺席 (OR 0.09 (OR 0.09) 0.02–0.32)) 或不愿提供血压读数（OR 0.22 (0.04–0.97)）。在报告的参与者中观察到更高的可接受性：以前通过邮寄方式接受药物治疗（OR 4.63 (1.44–14.8)），偏好送货上门而不是诊所收集（OR 24.1 (11.1–51.9)），偏好家庭 STI 检测（OR 10.3 (OR 10.3 (OR 10.3) 6.16–17.4))、与健康顾问沟通的能力（OR 4.01 (1.03–15.6)）并愿意：注册真实姓名（OR 3.09 (1.43–10.6)）、完成在线健康问卷调查（OR 3.09 (1.43–10.6)） )) 并使用通用避孕药（OR 2.88 (1.21–6.83)）。结论 邮政治疗和在线输入信息以允许远程开药是 SRH 服务可接受的方法，应与药房的药物收集一起考虑。这些方法对于在获得 SRH 方面面临障碍的患者可能特别有用。应进一步研究这些新型服务提供方法的成本效益和实施情况。可应合理要求提供数据。没有额外的数据。